Savchuk Nikolay — SEC Form 4 filings
SEC reporting owner CIK 2017800. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-15.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-03 to 2026-07-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | Chief Operating Officer, Director | 8 | — | — | 18 |
| Lomond Therapeutics Holdings, Inc. | President and COO, Director | 1 | — | — | 6 |
Form 4 filings — Savchuk Nikolay
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-15 | 4 | Traws Pharma, Inc. (TRAW) | Grant/award (A): 93,000 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Traws Pharma, Inc. (TRAW) | Grant/award (A): 96,899 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Traws Pharma, Inc. (TRAW) | Grant/award (A): 16,419 @ $0 · Grant/award (A): 65,676 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Traws Pharma, Inc. (TRAW) | Grant/award (A): 22,435 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Traws Pharma, Inc. (TRAW) jointly with TPAV, LLC | Other (J): 605,531 · Other (J): 2,263.75 (derivative) @ $0 | EDGAR |
| 2025-01-27 | 4 | Traws Pharma, Inc. (TRAW) | Purchase (P): 96,348 (derivative) · Purchase (P): 96,348 (derivative) | EDGAR |
| 2024-11-05 | 4 | Lomond Therapeutics Holdings, Inc. | Conversion (C): 539,062 @ $3.20 · Conversion (C): 694,444 @ $3.60 · Grant/award (A): 1,443,750 @ $4 · Grant/award (A): 1,258,000 (derivative) @ $0 · Conversion (C): 539,062 (derivative) @ $0 · Conversion (C): 694,444 (derivative) @ $0 | EDGAR |
| 2024-08-07 | 4/A | Traws Pharma, Inc. (TRAW) | Grant/award (A): 67,500 | EDGAR |
| 2024-04-03 | 4 | Traws Pharma, Inc. (TRAW) | Grant/award (A): 66,687 · Grant/award (A): 67,550 · Grant/award (A): 885,532 · Grant/award (A): 1,645,100 · Grant/award (A): 3,802,890 (derivative) · Grant/award (A): 194.62 (derivative) · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2017800 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →